EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs.
Davignon
J P
JP
Pharmaceutical Resources Branch, National Cancer Institute, Bethesda, MD.
Slack
J A
JA
Beijnen
J H
JH
Vezin
W R
WR
Schoemaker
T J
TJ
D000970:Antineoplastic Agents; D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D004349:Drug Packaging; D004355:Drug Stability; D004356:Drug Storage
D000970:Antineoplastic Agents